0001179110-21-010209.txt : 20211117
0001179110-21-010209.hdr.sgml : 20211117
20211117160432
ACCESSION NUMBER: 0001179110-21-010209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hewes L. Becker
CENTRAL INDEX KEY: 0001840110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 211420615
MAIL ADDRESS:
STREET 1: C/O BLUEPRINT MEDICINES
STREET 2: CORPORATION
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-11-15
0
0001597264
Blueprint Medicines Corp
BPMC
0001840110
Hewes L. Becker
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Common Stock
2021-11-15
4
M
0
729
66.24
A
26916
D
Common Stock
2021-11-15
4
S
0
729
115.49
D
26187
D
Stock Option (Right to Buy)
66.24
2021-11-15
4
M
0
729
0
D
2030-06-01
Common Stock
729
24792
D
Effected pursuant to a trading plan adopted on August 13, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on June 1, 2020. This option vested with respect to 25% of the shares underlying the option on June 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Ariel Hurley, Attorney-in-Fact
2021-11-17